Trial
NCT01656252
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
PrECOG, LLC.
Collaborators
GlaxoSmithKline; Novartis
Condition
Acute Myeloid Leukemia
Intervention
Phase I- Cytarabine & Eltrombopag
Why stopped
Study stopped per Novartis request due to futility from another study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-03